의료용 영상 진단 시약 시장 규모, 점유율, 성장 분석 : 유형별, 모달리티별, 기술별, 용도별, 지역별 - 업계 예측(2026-2033년)

Medical Imaging Reagents Market size was valued at USD 18.25 Billion in 2024 and is poised to grow from USD 19.2 Billion in 2025 to USD 28.8 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global medical imaging reagents market is an essential component of the healthcare sector, providing vital tools for diagnostics and research. These reagents enhance the contrast and visibility of specific tissues or organs in imaging techniques such as MRI, CT, ultrasound, and nuclear medicine. Key market drivers include the rising prevalence of chronic diseases, an increasing aging population, and the demand for early and accurate disease diagnosis. Medical imaging reagents significantly improve diagnostic accuracy and treatment planning, thereby facilitating better patient outcomes. There is a notable trend towards molecular imaging techniques, which require advanced reagents targeting specific molecules, enhancing disease characterization. Ongoing research aims to develop safer, more efficient reagents, while hybrid imaging systems are catalyzing demand for versatile solutions applicable across multiple imaging modalities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Imaging Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Imaging Reagents Market Segments Analysis

Global Medical Imaging Reagents Market is segmented by Class, Modality, Technology, Application and region. Based on Class, the market is segmented into Contrast reagents, Optical reagents and Nuclear reagents. Based on Modality, the market is segmented into X-ray, CT Scan, Ultrasound and MRI Scan. Based on Technology, the market is segmented into Nanoparticles, Fluorescent dyes & probes, Radiopharmaceuticals, Fluorescent proteins and Quantum dots. Based on Application, the market is segmented into Diagnostics, Drug discovery & development and Educational Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Medical Imaging Reagents Market

The rising incidence of chronic illnesses such as cancer, cardiovascular disorders, and neurological conditions has significantly heightened the demand for medical imaging techniques. Within this context, medical imaging reagents are essential, as they enhance both the precision and effectiveness of diagnostic imaging processes. This enhancement leads to improved patient outcomes and encourages healthcare providers to adopt these reagents more widely. As a result, the need for advanced imaging solutions continues to grow, driving the expansion of the medical imaging reagents market. This trend reflects a broader commitment to improving healthcare delivery through enhanced diagnostic capabilities.

Restraints in the Medical Imaging Reagents Market

The medical imaging reagents market faces a significant constraint due to the high costs associated with advanced imaging techniques such as PET and MRI. These reagents, along with the equipment and related healthcare services, present a considerable financial burden for both healthcare facilities and patients. This economic challenge can hinder market growth, particularly in regions with lower income levels, where access to such technologies is limited. The expensive nature of these imaging reagents impedes widespread adoption and may lead to disparities in healthcare quality, thereby potentially restricting advancements in medical imaging practices across various demographics.

Market Trends of the Medical Imaging Reagents Market

The Medical Imaging Reagents market is witnessing a notable shift driven by the growing demand for molecular imaging agents, particularly positron emission tomography (PET) and single-photon emission computed tomography (SPECT) radiopharmaceuticals. These advanced reagents enhance the ability to visualize and quantify biological processes at the molecular and cellular levels, significantly improving early disease detection, treatment planning, and monitoring. Continuous advancements in radiopharmaceutical development, focusing on the creation of more targeted and specific agents, are further fueling this trend. As healthcare increasingly prioritizes precision medicine, the need for innovative imaging reagents is expected to rise, thereby shaping the future landscape of medical diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis

Global Medical Imaging Reagents Market Size by Class & CAGR (2026-2033)

• Market Overview
• Contrast reagents
• Optical reagents
• Nuclear reagents

Global Medical Imaging Reagents Market Size by Modality & CAGR (2026-2033)

• Market Overview
• X-ray
• CT Scan
• Ultrasound
• MRI Scan

Global Medical Imaging Reagents Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Nanoparticles
• Fluorescent dyes & probes
• Radiopharmaceuticals
• Fluorescent proteins
• Quantum dots

Global Medical Imaging Reagents Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnostics
• Drug discovery & development
• Educational Research

Global Medical Imaging Reagents Market Size & CAGR (2026-2033)

• North America (Class, Modality, Technology, Application)
  • US
  • Canada
• Europe (Class, Modality, Technology, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Class, Modality, Technology, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Class, Modality, Technology, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Class, Modality, Technology, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Radiopharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nordion (Canada) Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curium Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Accelerator Applications (AAA) - A Novartis Company (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agfa-Gevaert Group (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Triad Isotopes Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Medi-Physics Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EczacIbasI-Monrol Nuclear Products (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations